Scientists at the Institute for Bioengineering of Catalonia (IBEC) and CIC biomaGUNE used a single dose of urea-powered, radioactive nanorobots to reduce bladder tumors in mice by 90%. The breakthrough could lead to the development of bladder cancer treatments that significantly reduce hospitalization time and costs. Existing bladder cancer treatments show low efficacy, with almost half of bladder tumors recurring within five years.
The True Cost of Focusing on Cost Instead of Cost-Effectiveness
When payors consider only the cost of the medication and not the cost and risk to the patient, doctor, and healthcare system, the irony is
